GAD autoantibodies in a selection-free population of insulin-treated diabetic patients:: indicator of a high prevalence of LADA?

被引：18

作者：

Schiel, R ^{[1
]}

Müller, UA ^{[1
]}

机构：

[1] Univ Jena, Sch Med, Dept Internal Med 2, D-07740 Jena, Germany

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2000年 / 49卷 / 01期

关键词：

anti-CAD; diabetes mellitus; type; 1; 2; diabetes long-term complications; latent autoimmune diabetes mellitus in adults (LADA);

D O I：

10.1016/S0168-8227(00)00139-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Up to the present only few data have been available concerning the prevalence of diabetes-specific autoantibodies (anti-GAD, ICA, IAA, IA-2) in unselected populations, in particular in type 2 diabetic patients. Hence, the aim of the present study was to determine the prevalence of anti-CAD in a selection-free population of insulin-treated diabetic patients. Accordingly, 90% of all the insulin-treated diabetic patients (type 1, n = 127, type 2, n = 117) aged 16-60 years and living in the city of Jena (100 242 inhabitants) were examined. In order to test sera for anti-CAD, serum samples were taken in 75% of type 1 (n = 95) and in 80% of insulin-treated type 2 diabetic (n = 94) patients. Results: In the group of type 1 diabetic patients 55% of the patients tested were positive for anti-CAD. But, interestingly, in the type 2 group, a total of 21% patients were positive. With respect to this high percentage of anti-CAD positive type 2 diabetic patients it must be suggested that the frequency of patients with latent autoimmune diabetes mellitus in adults (LADA) was underestimated in the past. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：33 / 40

页数：8

共 34 条

[21] PREVALENCE OF AUTOANTIBODIES TO THE 65-KD AND 67-KD ISOFORMS OF GLUTAMATE-DECARBOXYLASE IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

SEISSLER, J ;

AMANN, J ;

MAUCH, L ;

HAUBRUCK, H ;

WOLFAHRT, S ;

BIEG, S ;

RICHTER, W ;

HOLL, R ;

HEINZE, E ;

NORTHEMANN, W ;

SCHERBAUM, WA .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1394-1399

[22] Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM [J].

Seissler, J ;

Morgenthaler, NG ;

Achenbach, P ;

Lampeter, EF ;

Glawe, D ;

Payton, M ;

Christie, M ;

Scherbaum, WA .

DIABETOLOGIA, 1996, 39 (11) :1351-1356

[23] ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules [J].

Solimena, M ;

Dirkx, R ;

Hermel, JM ;

PleasicWilliams, S ;

Shapiro, JA ;

Caron, L ;

Rabin, DU .

EMBO JOURNAL, 1996, 15 (09) :2102-2114

[24] ANTIBODIES TO GAD IN JAPANESE DIABETIC-PATIENTS - A MULTICENTER STUDY [J].

TSURUOKA, A ;

MATSUBA, I ;

TOYOTA, T ;

ISSHIKI, G ;

NAGATAKI, S ;

IKEDA, Y .

DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 28 (03) :191-199

[25] ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE REVEAL LATENT AUTOIMMUNE DIABETES-MELLITUS IN ADULTS WITH A NON-INSULIN-DEPENDENT ONSET OF DISEASE [J].

TUOMI, T ;

GROOP, LC ;

ZIMMET, PZ ;

ROWLEY, MJ ;

KNOWLES, W ;

MACKAY, IR .

DIABETES, 1993, 42 (02) :359-362

[26] DEMONSTRATION OF GAD-65 AS THE MAIN IMMUNOGENIC ISOFORM OF GLUTAMATE-DECARBOXYLASE IN TYPE-1 DIABETES AND DETERMINATION OF AUTOANTIBODIES USING A RADIOLIGAND PRODUCED BY EUKARYOTIC EXPRESSION [J].

VELLOSO, LA ;

KAMPE, O ;

HALLBERG, A ;

CHRISTMANSON, L ;

BETSHOLTZ, C ;

KARLSSON, FA .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2084-2090

[27] ANTI-GLUTAMATE DECARBOXYLASE AND OTHER ANTIBODIES AT THE ONSET OF CHILDHOOD IDDM - A POPULATION-BASED STUDY [J].

VERGE, CF ;

HOWARD, NJ ;

ROWLEY, MJ ;

MACKAY, IR ;

ZIMMET, PZ ;

EGAN, M ;

HULINSKA, H ;

HULINSKY, I ;

SILVESTRINI, RA ;

KAMATH, S ;

SHARP, A ;

ARUNDEL, T ;

SILINK, M .

DIABETOLOGIA, 1994, 37 (11) :1113-1120

[28] PHOSPHOLIPID AND GLUTAMIC-ACID DECARBOXYLASE AUTOANTIBODIES IN DIABETIC NEUROPATHY [J].

VINIK, AI ;

LEICHTER, SB ;

PITTENGER, GL ;

STANSBERRY, KB ;

HOLLAND, MT ;

POWERS, AC ;

SUWANWALAIKORN, S .

DIABETES CARE, 1995, 18 (09) :1225-1232

[29] Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test [J].

WiestLadenburger, U ;

Hartmann, R ;

Hartmann, U ;

Berling, K ;

Bohm, BO ;

Richter, W .

DIABETES, 1997, 46 (04) :565-571

[30] A MULTICENTER STUDY OF THE PREVALENCE OF DIABETIC PERIPHERAL NEUROPATHY IN THE UNITED-KINGDOM HOSPITAL CLINIC POPULATION [J].

YOUNG, MJ ;

BOULTON, AJM ;

MACLEOD, AF ;

WILLIAMS, DRR ;

SONKSEN, PH .

DIABETOLOGIA, 1993, 36 (02) :150-154

← 1 2 3 4 →